Beximco Pharmaceuticals Plc.
(LSE) BXP
Beximco Pharmaceuticals Plc. Financials at a Glance
Market Cap
$18.09B
Revenue (TTM)
$46.34B
Net Income (TTM)
$6.35B
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Price
$40.55
Volume
0
Open
$42.50
Price
$40.55
Volume
0
Open
$42.50
Previous Close
$40.55
Daily Range
$40.55 - $40.55
52-Week Range
$31.55 - $52.33
Dividend
$0.00
Beta (Volatility)
-0.03 (Low)
Price
$40.55
Volume
0
Open
$42.50
Previous Close
$40.55
Daily Range
$40.55 - $40.55
52-Week Range
$31.55 - $52.33
BXP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Beximco Pharmaceuticals Plc.
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,122
CEO
Iqbal Ahmed
Website
www.beximcopharma.comHeadquarters
Dhaka, 1205, BD
BXP Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
20%
Net Income Margin
13%
Return on Equity
0%
Return on Capital
15%
Return on Assets
8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
27.20%
Stock Overview
Market Cap
$18.09B
Shares Outstanding
446.11M
Volume
0
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$19.63B
Operating Income
$8.67B
EBITDA
$10.64B
Operating Cash Flow
$8.36B
Capital Expenditure
$2.23B
Free Cash Flow
$6.13B
Cash & ST Invst.
$1.05B
Total Debt
$6.03B
Beximco Pharmaceuticals Plc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.30B
+12.8%
Gross Profit
$5.57B
+13.9%
Gross Margin
45.29%
N/A
Market Cap
$18.09B
N/A
Market Cap/Employee
$3.01M
N/A
Employees
6,000
N/A
Net Income
$1.83B
+27.6%
EBITDA
$2.61B
-4.2%
Quarterly Fundamentals
Net Cash
$3.84B
+38.7%
Accounts Receivable
$4.63B
+24.8%
Inventory
$15.10B
+12.7%
Long Term Debt
$2.02B
+11.5%
Short Term Debt
$4.17B
-28.0%
Return on Assets
8.41%
N/A
Return on Invested Capital
14.51%
N/A
Free Cash Flow
$279.87M
-121.7%
Operating Cash Flow
$1.04B
-41.0%